Skip to main content
MIRA
NASDAQ Life Sciences

MIRA's Ketamir-2 Clears FDA Review, Heads to IRB for Phase 2a CIPN Trial

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$0.71
Mkt Cap
$30.239M
52W Low
$0.6
52W High
$2.45
52W Position info
18% above low
Off High info
71% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

MIRA sits 18% above its 52-week low of $0.6 on light trading volume (0.1× avg).

Summary

MIRA Pharmaceuticals has completed FDA review of its Ketamir-2 Phase 2a protocol for chemotherapy-induced peripheral neuropathy (CIPN) and submitted it for IRB review at a leading cancer research institution. The company is targeting site initiation in Q1 2027. This is the first clinical evaluation of Ketamir-2 in patients, moving beyond Phase 1 healthy volunteer data. The study is a randomized, double-blind, placebo-controlled crossover design testing 300 mg and 600 mg doses. This follows the 8-K filed today announcing the FDA review completion. The company faces going concern risk with cash into Q1 2027, so advancing this asset is critical. Watch for IRB approval and site activation timing.

At the time of this announcement, MIRA was trading at $0.71 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $30.2M. The 52-week trading range was $0.60 to $2.45. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

MIRA - Latest Insights

MIRA
Nov 16, 2026, 4:06 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.6283
Real-time Price: $0.297 info
Change: -$0.3313 (-53%) info
Market Cap: $12.228M info
MIRA
Oct 28, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.5561
Real-time Price: $0.297 info
Change: -$0.2591 (-47%) info
Market Cap: $12.228M info
MIRA
Oct 22, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.681
Real-time Price: $0.297 info
Change: -$0.384 (-56%) info
Market Cap: $12.228M info
MIRA
Sep 17, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.7101
Real-time Price: $0.297 info
Change: -$0.4131 (-58%) info
Market Cap: $12.228M info
MIRA
Aug 12, 2026, 4:17 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.7387
Real-time Price: $0.297 info
Change: -$0.4417 (-60%) info
Market Cap: $12.228M info